Home » Topics » Musculoskeletal, BioWorld Science

Musculoskeletal, BioWorld Science
RSS

Pfizer discloses new CCR6 antagonists

April 7, 2020

Horizon Therapeutics acquires LPA1 receptor antagonist for dcSSc

April 6, 2020

A20's inflammation-fighting properties decoded

April 6, 2020

Roche identifies antagonists of Toll-like receptors

April 3, 2020

Butyrate affects regulatory B cells, rheumatoid arthritis

March 31, 2020

Roche synthesizes new TLR7/TLR8/TLR9 antagonists

March 30, 2020

Phase I data with inzomelid support progression to phase II

March 26, 2020

Aclaris initiates phase IIa study of ATI-450 with methotrexate for moderate to severe RA

March 16, 2020

Roche patents Toll-like receptor antagonists

March 13, 2020

Positive results presented from phase Ib portion of PREVAIL study of PRV-3279

March 13, 2020

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 10, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 9, 2026
Skape Bio unlocks GPCR targets with de novo-designed miniproteins
BioWorld
Modulating G protein-coupled receptors (GPCRs) is one of the major challenges in biomedicine. These are flexible proteins with small, deep binding pockets. The...
Antares Therapeutics divulges new CDK2/cyclin E1 inhibitors
BioWorld Science
Antares Therapeutics Inc. has reported new CDK2/cyclin E1 inhibitors potentially useful for the treatment of cancer.
Empire Discovery Institute, Univ. of Rochester identify IRAK inhibitors
BioWorld Science
Empire Discovery Institute and the University of Rochester have discovered new interleukin-1 receptor-associated kinase 1 (IRAK-1) and/or IRAK-4 inhibitors...